Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.2c00874
Abstract: Programmed cell death protein-1/ligand-1 (PD-1/PD-L1) checkpoint blockade is a major breakthrough in cancer therapy, but identifying patients likely to benefit from this therapy remains challenging. Immunohistochemistry is not informative about PD-L1 expression heterogeneity because of…
read more here.
Keywords:
hynic kn035;
spect imaging;
expression;
99mtc hynic ... See more keywords